Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
2008

Mycothiol is important for Mycobacterium tuberculosis to respond to ethionamide

publication Evidence: moderate

Author Information

Author(s): Catherine Vilchèze, Yossef Av-Gay, Rodgoun Attarian, Zhen Liu, Manzour H Hazbón, Roberto Colangeli, Bing Chen, Weijun Liu, David Alland, James C Sacchettini, William R Jacobs Jr

Primary Institution: Howard Hughes Medical Institute, Department of Microbiology and Immunology, Albert Einstein College of Medicine

Hypothesis

Mycothiol biosynthesis is required for ethionamide susceptibility in Mycobacterium tuberculosis.

Conclusion

The study found that mycothiol is not essential for the growth of Mycobacterium tuberculosis but is crucial for its susceptibility to ethionamide.

Supporting Evidence

  • Mutations in the mshA gene were identified in ethionamide-resistant Mycobacterium tuberculosis strains.
  • Mycothiol-deficient strains showed normal growth in immunodeficient mice.
  • The study demonstrated that mycothiol is not essential for growth in vitro or in vivo.

Takeaway

Mycothiol helps a germ called Mycobacterium tuberculosis fight off a medicine called ethionamide, but it doesn't need it to grow.

Methodology

The researchers isolated spontaneous mutants of Mycobacterium tuberculosis and analyzed their resistance to ethionamide and isoniazid, focusing on mutations in the mshA gene.

Limitations

The study did not explore all potential compensatory mechanisms for ethionamide resistance in the mutants.

Digital Object Identifier (DOI)

10.1111/j.1365-2958.2008.06365.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication